Translational Bioinformatics: Past, Present, and Future

Genomics, Proteomics and Bioinformatics

Volumn 14, Issue 1, 2016, Pages 31-41

  Tenenbaum, Jessica D ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Genomics; Personalized medicine; Precision medicine; Translational bioinformatics

Indexed keywords

BIOINFORMATICS; ELECTRONIC MEDICAL RECORD; MEDICAL RESEARCH; PERSONALIZED MEDICINE; PREDICTION; BIOLOGY; FACTUAL DATABASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; METABOLISM;

BIOLOGICAL MARKER;

BIOMARKERS; BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; PRECISION MEDICINE;

EID: 84969443677     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2016.01.003     Document Type: Review

References (54)

1. Tenenbaum J.D., Shah N.H., Altman R.B. Translational bioinformatics. Biomedical informatics 2014, 721-754. Springer-Verlag, London. E.H. Shortliffe, J.J. Cimino (Eds.).
2. Butte A.J., Chen R. Finding disease-related genomic experiments within an international repository: first steps in translational bioinformatics. AMIA Annual Symposium Proceedings 2006 2006, 106-110.
3. Denny J.C. Surveying recent themes in translational bioinformatics: big data in EHRs, omics for drugs, and personal genomics. Yearb Med Inform 2014, 9:199-205.
4. Kulynych J, Greely H. Every patient a subject: When personalized medicine, genomic research, and privacy collide 2014, http://www.slate.com/articles/technology/future_tense/2014/12/when_personalized_medicine_genomic_research_and_privacy_collide.
5. Hudson K.L., Collins F.S. Bringing the common rule into the 21st century. N Engl J Med 2015, 373:2293-2296.
6. Institute of Medicine (US) Roundtable on Evidence-Based Medicine Leadership commitments to improve value in healthcare: finding common ground: workshop summary 2009, National Academies Press (US), Washington (DC), http://www.ncbi.nlm.nih.gov/books/NBK52847/.
7. Fleurence R., Selby J.V., Odom-Walker K., Hunt G., Meltzer D., Slutsky J.R., et al. How the patient-centered outcomes research institute is engaging patients and others in shaping its research agenda. Health Aff 2013, 32:393-400.
8. Embi P.J., Payne P.R. Evidence generating medicine: redefining the research-practice relationship to complete the evidence cycle. Med Care 2013, 51:S87-S91.
9. Luce B.R., Kramer J.M., Goodman S.N., Connor J.T., Tunis S., Whicher D., et al. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 2009, 151:206-209.
10. Botsis T., Hartvigsen G., Chen F., Weng C. Secondary use of EHR: data quality issues and informatics opportunities. AMIA Jt Summits Transl Sci Proc 2010, 2010:1-5.
11. Frankovich J., Longhurst C.A., Sutherland S.M. Evidence-based medicine in the EMR era. N Engl J Med 2011, 365:1758-1759.
12. Longhurst C.A., Harrington R.A., Shah N.H. A 'green button' for using aggregate patient data at the point of care. Health Aff 2014, 33:1229-1235.
13. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
14. Kho A.N., Pacheco J.A., Peissig P.L., Rasmussen L., Newton K.M., Weston N., et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med 2011, 3:79re1.
15. Richesson R.L., Hammond W.E., Nahm M., Wixted D., Simon G.E., Robinson J.G., et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. J Am Med Inform Assoc 2013, 20:e226-e231.
16. Collins F.S., Hudson K.L., Briggs J.P., Lauer M.S. PCORnet: turning a dream into reality. J Am Med Inform Assoc 2014, 21:576-577.
17. Tenenbaum J.D., Christian V., Cornish M.A., Dolor R.J., Dunham A.A., Ginsburg G.S., et al. The MURDOCK study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am J Transl Res 2012, 4:291-301.
18. Rasmussen L.V., Thompson W.K., Pacheco J.A., Kho A.N., Carrell D.S., Pathak J., et al. Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform 2014, 51:280-286.
19. Richesson R.L., Rusincovitch S.A., Wixted D., Batch B.C., Feinglos M.N., Miranda M.L., et al. A comparison of phenotype definitions for diabetes mellitus. J Am Med Inform Assoc 2013, 20:e319-e326.
20. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
21. Pendergrass S.A., Ritchie M.D. Phenome-wide association studies: leveraging comprehensive phenotypic and genotypic data for discovery. Curr Genet Med Rep 2015, 3:92-100.
22. Denny J.C., Crawford D.C., Ritchie M.D., Bielinski S.J., Basford M.A., Bradford Y., et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet 2011, 89:529-542.
23. Pendergrass S.A., Brown-Gentry K., Dudek S., Frase A., Torstenson E.S., Goodloe R., et al. Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) network. PLoS Genet 2013, 9:e1003087.
24. Schadt E.E. The changing privacy landscape in the era of big data. Mol Syst Biol 2012, 8:612.
25. McCarthy J.J., McLeod H.L., Ginsburg G.S. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 2013, 5:189sr4.
26. Baskar S., Aziz P.F. Genotype-phenotype correlation in long QT syndrome. Glob Cardiol Sci Pract 2015, 2015:26.
27. Wilson M.R., Naccache S.N., Samayoa E., Biagtan M., Bashir H., Yu G., et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 2014, 370:2408-2417.
28. Johnson D.B., Dahlman K.H., Knol J., Gilbert J., Puzanov I., Means-Powell J., et al. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist 2014, 19:616-622.
29. Wagle N., Grabiner B.C., Van Allen E.M., Amin-Mansour A., Taylor-Weiner A., Rosenberg M., et al. Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med 2014, 371:1426-1433.
30. Tang Y., Axelsson A.S., Spegel P., Andersson L.E., Mulder H., Groop L.C., et al. Genotype-based treatment of type 2 diabetes with an alpha2A-adrenergic receptor antagonist. Sci Transl Med 2014, 6:257ra139.
31. Dewey F.E., Grove M.E., Pan C., Goldstein B.A., Bernstein J.A., Chaib H., et al. Clinical interpretation and implications of whole-genome sequencing. JAMA 2014, 311:1035-1045.
32. Mardis E.R. The $1,000 genome, the $100,000 analysis?. Genome Med 2010, 2:84.
33. Shameer K., Readhead B., Dudley J.T. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. Curr Top Med Chem 2015, 15:5-20.
34. Ban T.A. The role of serendipity in drug discovery. Dialogues Clin Neurosci 2006, 8:335-344.
35. Li J., Zheng S., Chen B., Butte A.J., Swamidass S.J., Lu Z. A survey of current trends in computational drug repositioning. Brief Bioinform 2015, 17:2-12.
36. Lamb J. The connectivity map: a new tool for biomedical research. Nat Rev Cancer 2007, 7:54-60.
37. Jahchan N.S., Dudley J.T., Mazur P.K., Flores N., Yang D., Palmerton A., et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov 2013, 3:1364-1377.
38. Sirota M., Dudley J.T., Kim J., Chiang A.P., Morgan A.A., Sweet-Cordero A., et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011, 3:96ra77.
39. Nygren P., Fryknas M., Agerup B., Larsson R. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. J Cancer Res Clin Oncol 2013, 139:2133-2140.
40. Altman R.B. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet 2007, 39:426.
41. Zhu Q., Tao C., Shen F., Chute C.G. Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging web ontology language (OWL) and cheminformatics approaches. Pac Symp Biocomput 2014, 172-182.
42. Hayden E.C. Out of regulatory limbo, 23andMe resumes some health tests and hopes to offer more. Nature 2015, 10.1038/nature.2015.18641.
43. Green R.C., Roberts J.S., Cupples L.A., Relkin N.R., Whitehouse P.J., Brown T., et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009, 361:245-254.
44. Tenenbaum J.D., James A., Paulyson-Nunez K. An altered treatment plan based on Direct to Consumer (DTC) genetic testing: personalized medicine from the patient/pin-cushion perspective. J Pers Med 2012, 2:192-200.
45. Gymrek M., McGuire A.L., Golan D., Halperin E., Erlich Y. Identifying personal genomes by surname inference. Science 2013, 339:321-324.
46. Vassy J.L., Lautenbach D.M., McLaughlin H.M., Kong S.W., Christensen K.D., Krier J., et al. The MedSeq project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials 2014, 15:85.
47. Sender R., Fuchs S., Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 2016, 164:337-340.
48. Foster J.A., Neufeld K.-A.M. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013, 36:305-312.
49. Mulle J.G., Sharp W.G., Cubells J.F. The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep 2013, 15:1-9.
50. Zhang Y., Liu D., Wang L., Wang S., Yu X., Dai E., et al. Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease. J Mol Med 2015, 93:1381-1390.
51. Yao C., Chen B.H., Joehanes R., Otlu B., Zhang X., Liu C., et al. Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes. Circulation 2015, 131:536-549.
52. Suhre K., Raffler J., Kastenmuller G. Biochemical insights from population studies with genetics and metabolomics. Arch Biochem Biophys 2015, 589:167-176.
53. Insel T.R., Cuthbert B.N. Medicine. Brain disorders? Precisely. Science 2015, 348:499-500.
54. Tenenbaum J.D., Sansone S.A., Haendel M. A sea of standards for omics data: sink or swim?. J Am Med Inform Assoc 2014, 21:200-203.